Clinicopathological Profiles Associated with Discordant
RAS
anti-EGFR therapy
colorectal cancer
ctDNA
liquid biopsy
mCRC
metastatic colorectal cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
12 Jul 2023
12 Jul 2023
Historique:
received:
06
06
2023
revised:
02
07
2023
accepted:
03
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
We aimed to identify common mCRC profiles associated with a discordant mutational status of
Identifiants
pubmed: 37509239
pii: cancers15143578
doi: 10.3390/cancers15143578
pmc: PMC10377339
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancers (Basel). 2019 Oct 08;11(10):
pubmed: 31597339
Lancet. 2019 Oct 19;394(10207):1467-1480
pubmed: 31631858
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Clin Cancer Res. 2017 Sep 15;23(18):5416-5425
pubmed: 28576867
Clin Adv Hematol Oncol. 2017 Jan;15(1):22-24
pubmed: 28212365
JCO Precis Oncol. 2022 Apr;6:e2100535
pubmed: 35544728
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Nat Med. 2023 Jan;29(1):127-134
pubmed: 36646802
Mol Oncol. 2017 Feb;11(2):208-219
pubmed: 28106345
J Clin Oncol. 2023 Jan 20;41(3):678-700
pubmed: 36252154
Clin Cancer Res. 2021 May 1;27(9):2505-2514
pubmed: 33547199
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
Front Oncol. 2020 Jul 16;10:1115
pubmed: 32766143
Gut. 2022 Jul;71(7):1340-1349
pubmed: 34489309
Ann Oncol. 2017 Jun 01;28(6):1294-1301
pubmed: 28368441
J Mol Diagn. 2017 Mar;19(2):183-186
pubmed: 28190460
Ann Oncol. 2023 Jan;34(1):111-120
pubmed: 36208697
Curr Colorectal Cancer Rep. 2019 Apr;15(2):61-69
pubmed: 31130830
Trends Mol Med. 2020 May;26(5):519-528
pubmed: 32359482
Br J Cancer. 2018 Dec;119(12):1464-1470
pubmed: 30467411
Ann Oncol. 2017 Aug 01;28(8):1713-1729
pubmed: 28407110
Eur J Cancer. 2017 Apr;75:3-4
pubmed: 28214423
Ann Oncol. 2018 May 1;29(5):1211-1219
pubmed: 29438522
Sci Rep. 2016 Jul 15;6:29765
pubmed: 27416752
Ann Oncol. 2022 Aug;33(8):750-768
pubmed: 35809752
Ann Oncol. 2014 Jul;25(7):1346-1355
pubmed: 24718886
PLoS One. 2020 Jul 2;15(7):e0235623
pubmed: 32614932
N Engl J Med. 2022 Jun 16;386(24):2330-2331
pubmed: 35657319
Ann Oncol. 2017 Sep 01;28(9):2149-2159
pubmed: 28911069
Ann Oncol. 2011 Jul;22(7):1535-1546
pubmed: 21228335
Int J Cancer. 2021 Sep 15;149(6):1385-1397
pubmed: 33961700
PLoS Med. 2021 May 3;18(5):e1003620
pubmed: 33939694
J Natl Compr Canc Netw. 2021 Mar 02;19(3):329-359
pubmed: 33724754
Nat Commun. 2019 Aug 19;10(1):3722
pubmed: 31427573
Clin Transl Oncol. 2020 Nov;22(11):1976-1991
pubmed: 32418154
Cancers (Basel). 2021 Nov 17;13(22):
pubmed: 34830904
Science. 2021 Apr 9;372(6538):
pubmed: 33833097
J Clin Oncol. 2011 May 20;29(15):2011-9
pubmed: 21502544
J Oncol Pract. 2017 May;13(5):333-337
pubmed: 28350513
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237
pubmed: 30285222
ESMO Open. 2019 Dec 1;4(6):e000599
pubmed: 31803504
Nature. 2012 Jun 28;486(7404):532-6
pubmed: 22722830
Ann Oncol. 2023 Jan;34(1):10-32
pubmed: 36307056
J Clin Oncol. 2011 Nov 20;29(33):4401-9
pubmed: 21969498
Br J Cancer. 2019 May;120(10):982-986
pubmed: 31015557
Front Oncol. 2020 Jun 16;10:964
pubmed: 32612957
CA Cancer J Clin. 2020 Nov;70(6):443-459
pubmed: 32940362
Clin Cancer Res. 2021 May 1;27(9):2515-2522
pubmed: 33602686
Ann Oncol. 2017 Jun 01;28(6):1325-1332
pubmed: 28419195
Ann Oncol. 2017 Dec 1;28(12):2943-2949
pubmed: 28945877
Cancer Cell. 2018 Jan 8;33(1):125-136.e3
pubmed: 29316426
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
JAMA Oncol. 2017 Feb 01;3(2):194-201
pubmed: 27722750
Clin Transl Oncol. 2019 Jan;21(1):46-54
pubmed: 30565083